ARUL KANNAN: Open Payments
NPI 1023008984 · NEW HARTFORD, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$904 in 44 payments from 11 companies in 2025. Trend: 2023 $1,087 · 2024 $1,291 · 2025 $904
Food & beverage: $904
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 18 | $393 |
| Lilly USA, LLC | 6 | $113 |
| ABBVIE INC. | 5 | $102 |
| GlaxoSmithKline, LLC. | 5 | $97 |
| Alexion Pharmaceuticals, Inc. | 2 | $53 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $34 |
| Indivior Inc. | 2 | $33 |
| Abbott Laboratories | 1 | $26 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Novo Nordisk Inc | 1 | $17 |
Products named: AIRSUPRA, BREZTRI, TRELEGY ELLIPTA, FARXIGA, MOUNJARO, JARDIANCE, STRENSIQ, LINZESS.
Industry payments across NY — which companies pay providers there.
